Literature DB >> 8813773

Management and follow-up of 78 giant haemangiomas of the liver.

A Pietrabissa1, P Giulianotti, A Campatelli, G Di Candio, F Farina, S Signori, F Mosca.   

Abstract

The natural history and appropriate treatment of giant liver haemangioma remain poorly defined. The diagnostic strategy and the results of a longitudinal study of 78 such lesions are described. Sixteen resected patients and 62 with asymptomatic giant haemangiomas were entered into a follow-up programme consisting of clinical assessment and abdominal ultrasonography every 6 months. Resection was considered only for symptomatic patients (14 cases) and rapidly growing lesions (two cases). The mean follow-up was 36 months for the resected patients and 55 months for the observed group. Surgery permanently relieved symptoms. No recurrence of haemangioma was observed. Some 32 of 36 unresected lesions followed up remained stable in size. Minor changes were observed in four of 36. None ruptured or became symptomatic. It is concluded that asymptomatic large haemangiomas can be managed safely by observation. However, the occasional occurrence of rapid growth might represent a further indication for resection and justifies strict imaging follow-up. The pattern of growth, rather than absolute size, of a lesion is suggested for selection of asymptomatic patients who might benefit from preventive surgical excision. When feasible, the authors prefer enucleation to remove giant haemangiomas.

Entities:  

Mesh:

Year:  1996        PMID: 8813773     DOI: 10.1002/bjs.1800830710

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  20 in total

1.  Differential diagnoses and diagnostic troubleshooting of upper abdominal masses.

Authors:  Danielle A Bischof; Michael A Choti
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-06

2.  Hemangioma of the spleen: presentation, diagnosis, and management.

Authors:  T M Willcox; R W Speer; R T Schlinkert; M G Sarr
Journal:  J Gastrointest Surg       Date:  2000 Nov-Dec       Impact factor: 3.452

3.  Management of hemangioma of the liver: surgical therapy or observation?

Authors:  Süleyman Yedibela; Sedat Alibek; Volker Müller; Unal Aydin; Melanie Langheinrich; Clemens Lohmüller; Werner Hohenberger; Aristotelis Perrakis
Journal:  World J Surg       Date:  2013-06       Impact factor: 3.352

4.  Multiple liver hemangiomas enlargement during long-term steroid therapy for myasthenia gravis.

Authors:  T Takahashi; S Kuwao; H Katagiri; A Kakita
Journal:  Dig Dis Sci       Date:  1998-07       Impact factor: 3.199

5.  Giant hemangiomas of the liver: surgical strategies and technical aspects.

Authors:  P Berloco; P Bruzzone; G Mennini; F Della Pietra; M Iappelli; G Novelli; M Rossi
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

6.  Hepatic resection for benign non-cystic liver lesions.

Authors:  D L Clarke; E J Currie; K K Madhavan; R W Parks; O J Garden
Journal:  HPB (Oxford)       Date:  2004       Impact factor: 3.647

7.  [Incidentalomas of the liver and gallbladder. Evaluation and therapeutic procedure].

Authors:  Carl Zülke; H J Schlitt
Journal:  Chirurg       Date:  2007-08       Impact factor: 0.955

8.  Impact on liver cancer treatment of a first erroneous diagnosis of hemangioma.

Authors:  Nazario Portolani; Gianluca Baiocchi; Federico Gheza; Sarah Molfino; Luigi Grazioli; Lucio Olivetti; Laura Romanini; Eleonora Frassi; Stefano Maria Giulini
Journal:  World J Surg       Date:  2014-10       Impact factor: 3.352

9.  Hepatic haemangiomas: possible association with female sex hormones.

Authors:  V Glinkova; O Shevah; M Boaz; A Levine; H Shirin
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

10.  Cystadenomas of the pancreas: is enucleation an adequate operation?

Authors:  M A Talamini; R Moesinger; C J Yeo; B Poulose; R H Hruban; J L Cameron; H A Pitt
Journal:  Ann Surg       Date:  1998-06       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.